Food and Drug Administration Research Grants (Assistance Listing 93.103)
Administered by Food and Drug Administration. An Assistance Listing is the permanent catalog entry for a federal funding program — individual opportunities are issued under it and come and go.
Overview
Assistance Listing 93.103 — Food and Drug Administration Research — is a federal funding program administered by Food and Drug Administration. UseGrants has tracked 56 funding opportunities issued under it by 2 agencies or sub-agencies, of which 9 are accepting applications right now. A further 30 are forecast — announced by the agency but not yet open. The typical award ceiling is $750,000, with the largest at $2,500,000. Historically, opportunities under this listing post most often in November and July.
Eligibility is set per opportunity, not per listing. The free UseGrants check matches your organization type and focus against every open opportunity, including these.
- Open now
- 9
- Forecast
- 30
- Opportunities tracked
- 56
- Typical ceiling
- $750K
- Largest ceiling
- $2.5M
- Assistance Listing
- 93.103
Open opportunities under 93.103
9 opportunities are accepting applications, newest first. Confirm every detail on the issuing agency’s official listing before you apply.
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH/CDC/FDA SBIR program (R43/R44) funds U.S. small businesses developing scientific innovations toward commercial products through feasibility and R&D studies. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityReissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Due May 16, 2028Food and Drug Administration · Up to $900K
Open to nearly any organization — universities, nonprofits (with or without 501(c)(3)), for-profits and small businesses, state/local/tribal governments, and foreign organizations. This FDA R01 funds clinical trials of orphan products evaluating safety and efficacy to address unmet needs in rare diseases. Awards up to about $900,000; clinical trials are required.
ResearchersNonprofitsSmall businessGovernment / tribal+3 moreReissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Due Feb 8, 2028Food and Drug Administration · Up to $600K
This FDA award (up to $600,000) funds natural history studies that generate high-quality data to support medical product development for rare diseases with unmet needs. Eligibility is very broad, covering universities, nonprofits (with or without 501(c)(3) status), small and other for-profit businesses, tribal and local/state governments, and even foreign organizations and their non-U.S. components. No unusual disqualifiers are noted, and the deadline is not imminent.
NonprofitsSmall businessResearchersSchools & universities+3 moreNARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Due Apr 1, 2027Food and Drug Administration · Up to $200K
This FDA cooperative agreement funds state and academic partners to strengthen antibiotic-resistance surveillance in retail food specimens as part of the NARMS program. Eligibility is broad, spanning universities, nonprofits (with or without 501(c)(3) status), small and large businesses, and state, local, and tribal governments. Awards range up to $200,000.
NonprofitsSmall businessGovernment / tribalBroad eligibilityAnimal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Due Apr 1, 2027Food and Drug Administration · Up to $300K
This FDA cooperative agreement funds state animal food safety programs working toward or maintaining full implementation of national inspection standards, with optional add-ons for mutual-reliance partnerships. It's restricted to state programs that already hold an active FDA inspectional contract and a valid prior agreement — a narrow, technical bar that rules out most nonprofits and businesses. Awards go up to $300,000 depending on funding track and tier.
Government / tribalNarrow eligibilityLaboratory Flexible Funding Model (LFFM)
Due Jan 11, 2028Food and Drug Administration · Up to $1.5M
An FDA cooperative agreement (Laboratory Flexible Funding Model) to strengthen state human and animal food testing laboratories through sample testing, food-defense preparedness, and method development. Eligibility is narrow: applicants must be ISO 17025 accredited (or have an equivalent quality system) and, for most tracks, hold a valid 20.88 agreement with FDA before applying. Awards run up to about $1.5 million. This is largely limited to established state food-testing laboratories that already meet the accreditation and FDA-agreement requirements.
Government / tribalLarge awardNarrow eligibilityAnimal and Veterinary Innovation Centers (U18)
Due May 12, 2028Food and Drug Administration · Up to $1.3M
Open to public and private higher-education institutions, including HBCUs, tribal colleges, and other minority-serving institutions. This FDA U18 forms long-term academic partnerships to research avian influenza and emerging zoonotic threats, intentional genomic alterations in animals, and products for minor and veterinary species. Awards up to about $1,250,000.
Schools & universitiesResearchersGovernment / tribalLarge awardMinor Use Minor Species Development of Drugs (R01)
Due Jan 29, 2027Food and Drug Administration · Up to $250K
An FDA R01 funding safety and effectiveness testing to support approval of drugs for minor uses or minor species (MUMS) in veterinary medicine. Eligibility is limited to entities developing such drugs (or their research partners) that already hold an INAD file and a MUMS designation from FDA/CVM, with a protocol pre-reviewed by FDA, so this requires existing regulatory standing with FDA. Awards reach up to about $250,000. Not a fit unless the applicant is already in the FDA veterinary drug development pipeline.
ResearchersSmall businessNarrow eligibilityVet-LIRN Capacity-Building Project and Equipment Grants (U18)
Due Sep 4, 2028Food and Drug Administration · $225K–$2.5M
This FDA grant (U18, $225,000 to $2,500,000) funds veterinary diagnostic laboratories in the Vet-LIRN network to build capacity for animal food safety and antimicrobial resistance testing, including equipment and method development. Eligibility is broad, covering nonprofits (with or without 501(c)(3) status), small businesses, for-profit organizations, universities, tribal governments, and state/local governments. No unusual disqualifiers are noted, and the deadline is not imminent.
NonprofitsSmall businessGovernment / tribalSchools & universities+2 more
Forecast opportunities under 93.103
30 opportunities have been announced by the issuing agency but are not accepting applications yet. Forecast notices usually carry no deadline and no application package until they post.
Previously issued under this listing
Past rounds are the best guide to what the next one will look like — the scope, the award size, and the time of year it lands.
| Opportunity | Award range | Closed |
|---|---|---|
| Retail Food Safety Regulatory Association Collaboration | Up to $750K | Closed |
When 93.103 opportunities post
Across the 56 opportunities UseGrants has tracked under this listing, postings cluster in November, July, August, May. Federal program cycles repeat, so a listing that missed you this year is worth watching for the next round.
- November17 opportunities
- July15 opportunities
- August14 opportunities
- May4 opportunities
Agencies issuing under 93.103
- Food and Drug Administration55 opportunities
- National Institutes of Health1 opportunity
What is Assistance Listing 93.103?
93.103 is the federal Assistance Listing (formerly CFDA) number for Food and Drug Administration Research, administered by Food and Drug Administration. An Assistance Listing is the permanent catalogue entry for a funding program; individual notices of funding opportunity are issued under it, each with its own deadline and eligibility. UseGrants has tracked 56 such notices.
Are there open 93.103 grants right now?
Yes — 9 opportunities are currently accepting applications under 93.103, listed on this page with their deadlines and award amounts. 30 more are forecast: announced, but not yet open to applicants. Verify each on the issuing agency's official listing before you apply.
How much funding do 93.103 grants award?
The typical award ceiling for an opportunity under 93.103 is $750,000, ranging up to $2,500,000. Award floors and ceilings are set per opportunity — check the specific notice you intend to apply to.
Which agencies issue grants under 93.103?
Food and Drug Administration, National Institutes of Health have issued the opportunities UseGrants tracks under this listing. UseGrants is an independent aggregator compiling public Grants.gov records — always confirm current details on the agency's own listing.
Who applies to 93.103, and what it sits alongside
Related federal programs
Source: public Grants.gov opportunity records. Assistance Listing numbers and program titles are as published by the issuing agency. UseGrants is an independent aggregator, not a federal agency — always confirm the current deadline, eligibility and award amount on the official listing before you apply.